Amalgam Rx, a Wilmington, DE-based company which specializes in enabling data-driven health care decision making, received an investment of undisclosed amount from CVS Health Ventures in its Series B round.
The company intends to use the funds to expand operations and its business reach. The investment supports the scaling of Amalgam’s EHR-integrated clinical decision support platform to provide actionable information for health care providers (HCPs) for use at the point of care.
Led by CEO Ryan Sysko, Amalgam helps patients and providers make decisions possible–in the provider workflow and in patients’ everyday lives. Its suite of AI-powered EHR Solutions and SaMD platform enable life sciences companies, health plans, and provider organizations to deliver better care collaboratively. Today, Amalgam’s algorithms and applications support patients across four continents and have helped providers make over 50m clinical decisions. Its solutions are powered by billions of RWE streaming data points across its platform.
In addition to the CVS Health Ventures investment, Aetna®, a CVS Health® company, is collaborating with Amalgam at select health systems, implementing its EHR-integrated decision support solutions, which are designed to improve outcomes and reduce the cost of care for Aetna members.
FinSMEs
06/10/2023